Mallinckrodt plc Reports Fourth Quarter and Fiscal Year 2024 Financial Results and Provides 2025 Guidance [Yahoo! Finance]
Medtronic plc. Ordinary Shares (MDT)
Last medtronic plc. ordinary shares earnings: 2/18 06:45 am
Check Earnings Report
US:NYSE Investor Relations:
investorrelations.medtronic.com
Company Research
Source: Yahoo! Finance
Grew Full-Year Net Sales by 6.1% to $2.0 Billion , with 14.2% Growth in Acthar ® Gel (repository corticotropin injection) and 15.4% Growth in Specialty Generics; Reduced Total Debt by 47% and Net Debt by Approximately 64% Acthar Gel Returned to Growth with Successful Launch of SelfJect™ Device; Uptake of INOmax ® EVOLVE™ DS Delivery System Accelerated in Second Half of the Year Expects 2025 Net Sales of $1.7 Billion to $1.8 Billion and Adjusted EBITDA of $480 Million to $520 Million DUBLIN March 13, 2025 /PRNewswire/ -- Mallinckrodt plc Mallinckrodt " or the "Company"), a global specialty pharmaceutical company, today reported its financial results for the fourth quarter and fiscal year ended December 27, 2024 Mallinckrodt logo "Our strong performance in 2024 reflects the disciplined execution of our strategy to position Mallinckrodt for long-term success," said Siggi Olafsson , President and Chief Executive Officer. "In Specialty Brands, Acthar Gel returned to growth, mark
Show less
Read more
Impact Snapshot
Event Time:
MDT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MDT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MDT alerts
High impacting Medtronic plc. Ordinary Shares news events
Weekly update
A roundup of the hottest topics
MDT
News
- Medtronic: A Defensive Gem For Uncertain Times [Seeking Alpha]Seeking Alpha
- Medtronic announces filing of IPO registration statement for Diabetes business, MiniMedPR Newswire
- Medtronic (NYSE:MDT) had its price target lowered by analysts at Truist Financial Corporation from $110.00 to $107.00. They now have a "hold" rating on the stock.MarketBeat
- Medtronic (NYSE:MDT) was given a new $103.00 price target on by analysts at Robert W. Baird.MarketBeat
- Medtronic plc declares $0.71 dividend [Seeking Alpha]Seeking Alpha
MDT
Earnings
- 11/18/25 - Beat
MDT
Sec Filings
- 12/17/25 - Form 4
- 12/17/25 - Form 4
- 12/17/25 - Form 4
- MDT's page on the SEC website